The Nose Knows

The latest news in geriatric psychiatry covers olfactory deficits in cognitively impaired patients, a smartphone app for older adults with serious mental illness, and adjunctive ketamine for late-life depression.

Related Videos
Related Content

Rx Evolution: An Ununified Model of MDD and Pharmacological Paradigms

February 6th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder

January 25th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

The Many Faces of Catatonia, An Under-Recognized Clinical Syndrome

January 23rd 2023

CRP as a Biomarker of Antidepressant Efficacy

January 20th 2023

Rx Evolution: An Ununified Model of MDD and Pharmacological Paradigms

February 6th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder

January 25th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

The Many Faces of Catatonia, An Under-Recognized Clinical Syndrome

January 23rd 2023

CRP as a Biomarker of Antidepressant Efficacy

January 20th 2023

Rx Evolution: An Ununified Model of MDD and Pharmacological Paradigms

February 6th 2023

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021

Positive Results from Phase 2a Trial of Psychedelic for Major Depressive Disorder

January 25th 2023

Blue Light, Depression, and Bipolar Disorder

August 4th 2021

The Many Faces of Catatonia, An Under-Recognized Clinical Syndrome

January 23rd 2023

CRP as a Biomarker of Antidepressant Efficacy

January 20th 2023
Advertise
Contact Us
Editorial
Terms and Conditions
Privacy Policy
Do Not Sell My Personal Information
Contact Info

2 Clarke Drive
Cranbury, NJ 08512

609-716-7777

© 2023 MJH Life Sciences

All rights reserved.